Clinical application of 5α-reductase inhibitors

被引:38
作者
Cilotti, A [1 ]
Danza, G [1 ]
Serio, M [1 ]
机构
[1] Univ Florence, Dept Clin Physiopathol, Endocrine Unit, I-50139 Florence, Italy
关键词
5; alpha-reductase; inhibitors; prostate cancer; BPH; hirsutism; baldness; acne;
D O I
10.1007/BF03343844
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The inhibitors of 5 alpha -reductase isoenzymes (1 and 2) can be schematically divided in three groups according they substrate specificity: a) pure or preferential inhibitor of 5 alpha -reductase 1; b) pure or preferential inhibitor of 5 alpha -reductase 2; c) dual inhibitors. Despite the fact that several steroidal and non-steroidal inhibitors have been synthesized and experimented in pharmacological models, only finasteride has been extensively used for clinical purposes. The largest application of finasteride in man has been human benign prostative hyperplasia (BPH). In addition, finasteride has been recently used for treatment of male baldness with a 50% of objective response. In women, finasteride has been used in some control trials for treatment of hirsutism with an objective favorable response. In conclusion, finasteride appears be useful for BPH, baldness and hirsutism (with caution) treatment. On the basis of experimental observations on distribution of 1 and 2 isoenzymes in human skin, scalp and prostate, the dual inhibitors should be more indicated for treatment of BPH and baldness. Similarly, the dual inhibitors seem indicated in attempting to prevent prostatic cancer. The pure 5a-reductase 1 inhibitors seem the ideal drugs for treatment of acne and hirsutism.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 33 条
  • [1] Bayne EK, 1999, BRIT J DERMATOL, V141, P481
  • [2] Bonkhoff H, 1996, PROSTATE, V29, P261, DOI 10.1002/(SICI)1097-0045(199610)29:4<261::AID-PROS7>3.0.CO
  • [3] 2-E
  • [4] Boudon C, 1995, CELL MOL BIOL, V41, P1007
  • [5] Effect of a vitamin D3 analogue on keratinocyte growth factor-induced cell proliferation in benign prostate hyperplasia
    Crescioli, C
    Maggi, M
    Vannelli, GB
    Luconi, M
    Salerno, R
    Barni, T
    Gulisano, M
    Forti, G
    Serio, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) : 2576 - 2583
  • [6] THE EFFECT OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR, ON SCALP SKIN TESTOSTERONE AND DIHYDROTESTOSTERONE CONCENTRATIONS IN PATIENTS WITH MALE PATTERN BALDNESS
    DALLOB, AL
    SADICK, NS
    UNGER, W
    LIPERT, S
    GEISSLER, LA
    GREGOIRE, SL
    NGUYEN, HH
    MOORE, EC
    TANAKA, WK
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (03) : 703 - 706
  • [7] Genetic analysis of male pattern baldness and the 5α-reductase genes
    Ellis, JA
    Stebbing, M
    Harrap, SB
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (06) : 849 - 853
  • [8] DESIGN OF THE PROSTATE-CANCER PREVENTION TRIAL (PCPT)
    FEIGL, P
    BLUMENSTEIN, B
    THOMPSON, I
    CROWLEY, J
    WOLF, M
    KRAMER, BS
    COLTMAN, CA
    BRAWLEY, OW
    FORD, LG
    [J]. CONTROLLED CLINICAL TRIALS, 1995, 16 (03): : 150 - 163
  • [9] 6-AZASTEROIDS - STRUCTURE-ACTIVITY-RELATIONSHIPS FOR INHIBITION OF TYPE-1 AND TYPE-2 HUMAN 5-ALPHA-REDUCTASE AND HUMAN ADRENAL 3-BETA-HYDROXY-DELTA(5)-STEROID DEHYDROGENASE 3-KETO-DELTA(5)-STEROID ISOMERASE
    FRYE, SV
    HAFFNER, CD
    MALONEY, PR
    MOOK, RA
    DORSEY, GF
    HINER, RN
    CRIBBS, CM
    WHEELER, TN
    RAY, JA
    ANDREWS, RC
    BATCHELOR, KW
    BRAMSON, HN
    STUART, JD
    SCHWEIKER, SL
    VANARNOLD, J
    CROOM, S
    BICKETT, DM
    MOSS, ML
    TIAN, GC
    UNWALLA, RJ
    LEE, FW
    TIPPIN, TK
    JAMES, MK
    GRIZZLE, MK
    LONG, JE
    SCHUSTER, SV
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (15) : 2352 - 2360
  • [10] 6-AZASTEROIDS - POTENT DUAL INHIBITORS OF HUMAN TYPE-1 AND 2 STEROID 5-ALPHA-REDUCTASE
    FRYE, SV
    HAFFNER, CD
    MALONEY, PR
    MOOK, RA
    HINER, RN
    BATCHELOR, KW
    BRAMSON, HN
    STUART, JD
    SCHWEIKER, SL
    VANARNOLD, J
    BICKETT, DM
    MOSS, ML
    TIAN, GC
    UNWALLA, RJ
    LEE, FW
    TIPPIN, TK
    JAMES, MK
    GRIZZLE, MK
    LONG, JE
    SCHUSTER, SV
    DORSEY, GF
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (26) : 4313 - 4315